BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

T2 Biosystems

T2 Biosystems logo

Founded
2006
Geography
United States of America based
Funding
$186.800 M

T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts utilizing T2MR target sepsis, hemostasis and Lyme disease, which are areas of significant unmet medical need in which existing therapies could be more effective with improved diagnostics.

Technologies

Nanomedicine  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet